As part of its rulemaking process, the U.S. Food and Drug Administration (FDA) is required to conduct an economic impact analysis that assesses the costs and benefits of proposed regulations and to select the option that maximizes the net economic benefit. There are numerous challenges inherent in conducting this type of analysis, from fully.assessing the various costs and benefits of proposed rules to quantifying these costs and benefits, often with incomplete data and evidence. The comments provided to FDA on the economic impact analysis contained in its proposed rule on required warnings for cigarette packages and advertisements highlighted these challenges. The overarching aim of this project is to produce new evidence that will inform and refine the FDA's economic impact assessments of future proposed rules. This will be done through a combination of behavioral economics experiments with original data collection, acquisition of existing archival, survey, and commercial databases, and merged data analyses that address the issues discussed above, as well as others that emerge in coming years. To accomplish this, a variety of . activities vvili be done to address three specific aims that together address most of the FDA's research priorities around understanding the role of economics and policies on tobacco use and perceptions.
Aim 1 : assess the impact of FDA regulatory actions and other tobacco control policies on tobacco use and related outcomes, including the impact on trajectories of tobacco use among young people and adults, the differential impact of these actions on disparate populations, and the differential impact on the use of traditional and emerging tobacco products.
Aim 2 : Assess the impact of FDA regulatory actions and other tobacco control policies on the consumer surplus obtained by tobacco users through a behavioral economics experiment that will quantify the extent of present bias, projection bias, and time inconsistencies in decisions about tobacco use and the implications of these biases for assessing changes in consumer surplus.
Aim 3 : Extend the range of costs and benefits including in assessing the economic impact of FDA regulatory actions to include a broader set of health and economic benefits than that included in previous FDA assessments.

Public Health Relevance

There are numerous challenges inherent in conducting the type of economic impact analysis FDA is required to conduct as part of its rulemaking process. This project will produce new evidence that addresses these challenges and better informs the FDA's economic impact assessments of future proposed rules concerning tobacco products.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgia State University
United States
Zip Code
Weaver, Scott R; Huang, Jidong; Pechacek, Terry F et al. (2018) Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of U.S. adult smokers, 2015-2016. PLoS One 13:e0198047
Ngo, Anh; Cheng, Kai-Wen; Shang, Ce et al. (2018) Global Evidence on the Association between Cigarette Graphic Warning Labels and Cigarette Smoking Prevalence and Consumption. Int J Environ Res Public Health 15:
Yang, Bo; Spears, Claire Adams; Popova, Lucy (2018) Psychological distress and responses to comparative risk messages about electronic and combusted cigarettes. Addict Behav :
Yang, Bo; Liu, Jiaying; Popova, Lucy (2018) Targeted Versus Nontargeted Communication About Electronic Nicotine Delivery Systems in Three Smoker Groups. Int J Environ Res Public Health 15:
Majeed, Ban A; Nyman, Amy; Sterling, Kymberle L et al. (2018) Little cigars and cigarillos: Affect and perceived relative harm among U.S. adults, 2015. Addict Behav 85:107-112
Pechacek, Terry Frank; Nayak, Pratibha; Slovic, Paul et al. (2018) Reassessing the importance of 'lost pleasure' associated with smoking cessation: implications for social welfare and policy. Tob Control 27:e143-e151
Spears, Claire Adams; Jones, Dina M; Weaver, Scott R et al. (2018) Motives and perceptions regarding electronic nicotine delivery systems (ENDS) use among adults with mental health conditions. Addict Behav 80:102-109
Weaver, Scott R; Kim, Hyoshin; Glasser, Allison M et al. (2018) Establishing consensus on survey measures for electronic nicotine and non-nicotine delivery system use: Current challenges and considerations for researchers. Addict Behav 79:203-212
Yang, Bo; Owusu, Daniel; Popova, Lucy (2018) Testing messages about comparative risk of electronic cigarettes and combusted cigarettes. Tob Control :
Gibson, Laura A; Creamer, MeLisa R; Breland, Alison B et al. (2018) Measuring perceptions related to e-cigarettes: Important principles and next steps to enhance study validity. Addict Behav 79:219-225

Showing the most recent 10 out of 50 publications